期刊文献+

环格列酮通过PPARγ及P38 MAPK信号途径诱导白血病HL-60细胞凋亡 被引量:2

Pro-apoptotic effect of ciglitazone in leukemic HL-60 cells via PPARγ and P38 MAPK signaling pathway Pro-apoptotic effect of ciglitazone in leukemic HL-60 cells via PPARγ and P38 MAPK signaling pathway
原文传递
导出
摘要 目的 探讨过氧化物酶体增殖物激活受体γ(PPARγ)激动剂环格列酮(CGZ)对白血病HL-60细胞的增殖抑制作用及其作用机制.方法 以不同浓度的CGZ(10~50μmol/L)作用于体外培养的HL-60细胞24、48、72 h,应用四甲基偶氮唑盐(MTT)法检测细胞生长抑制率,琼脂糖凝胶电泳检测细胞凋亡时的DNA梯状条带,流式细胞术(FCM)及膜联蛋白V(Annexin-V)/碘化丙啶(PI)双染色法检测CGZ单独及联合PPARγ拮抗剂GW9662作用后细胞凋亡率的变化,反转录-聚合酶链反应(RT-PCR)及Western印迹检测药物作用后PPARγ表达水平的变化,并对半胱氨酸蛋白酶3(caspase-3)及丝裂原活化蛋白激酶(MAPK)信号转导通路相关蛋白的表达水平进行检测.结果 30 μmol/L以上的CGZ可显著抑制细胞的生长,并呈现出明显的量-效与时-效关系.药物作用后72 h50 μmol/L CGZ对细胞的生长抑制率为84%±11%,明显高于40、30μmol/L CGZ对细胞的生长抑制率(72%±13%、59%±13%,P<0.01),而且药物作用72 h后在琼脂糖凝胶电泳上可见典型的DNA梯状条带.RT-PCR及Western印迹结果表明,作用72 h后随着药物浓度的升高,PPARγ mRNA及蛋白的表达水平均逐渐升高,5μmol/L GW9662可以部分阻滞PPARγ的表达.FCM检测结果显示,CGZ(50 μmol/L)诱导的细胞凋亡只能部分被GW9662所阻滞(药物作用后72 h,CGZ诱导的细胞凋亡率为49.7%,CGZ+GW9662的细胞凋亡率为36.2%,未加药对照组为3.2%).Western印迹检测结果显示,MAPK信号途径中磷酸化P38(p-P38)的表达水平随药物浓度逐渐升高,同时caspase-3被活化出现相对分子质量为20 000的亚单位.结论 CGZ可以通过PPARγ依赖性和非依赖性途径诱导HL-60细胞凋亡,通过caspase-3活化以及激活P38 MAPK信号途径是CGZ诱导白血病HL-60细胞发生凋亡的重要作用机制之一. Objective To investigate the apoptosis-inducing effect of peroxisome proliferator-activated receptor γ (PPARγ) agonist ciglitazone (CGZ)on leukemic HL-60 cells and its mechanisms of action. Methods HL-60 cells in vitro culture medium were subject to different concentrations of CGZ (10-50 μmol/L) for 24, 48 and 72 h. MTT assay was used to detect the cell inhibitory rate and agarose gel electrophoresis to observe DNA fragmentation. Flow cytometry (FCM) and Annexin V/PI staining were used to detect CGZ and/or GW9662 ( PPARγ antagonist)-induced cell apoptosis. The expression of PPARγ was examined by RT-PCR and Western bloting. The caspase-3 and protein levels in mitogen-activated protein kinase signaling pathways (MAPKs, p-P38, p-ERK and p-JNK) were also detected. Results CGZ (over 30 μmol/L) could inhibit the growth of HL-60 cells in both time- and dose-dependent manner. After treatment for 72 h, the cell growth inhibitory rate in 50 μmol/L CGZ (84% ± 11% ) treated cells was found more higher than that in both 40 μmol/L and 30 μmol/L CGZ treated cells (72% ± 13% ,59% ± 13% ,P 〈0.01 ) and a typical DNA ladder was also observed by agarose gel electrophoresis. The expression of PPARγ was gradually up-regulated by CGZ treatment and could be down-regulated partially by PPARγ antagonist GW9662. The results also revealed that CGZ-induced cell apoptosis(49.7% ,72 h)could not be inhibited thoroughly by GW9662 ( 36. 2%, control: 3.2% ). It indicated that the CGZ-induced cell apoptosis was partially PPARγ-independent. Western bloting showed a cleavage of caspase-3 zymogen protein and upregulation of p-P38 protein. Thus it indicated that the activations of caspase-3 and P38 MAPK were involved in CGZ-induced cell apoptosis. Conclusion CGZ inhibits cell growth by induction of cell apoptosis in HL-60 cells via PPARγ dependent and independent signaling pathways. The activations of caspase-3 and P38MAPK may be one of the important mechanisms in CGZ in treated HL-60 cells.
出处 《中华医学杂志》 CAS CSCD 北大核心 2010年第32期2270-2274,共5页 National Medical Journal of China
基金 基金项目:国家自然科学基金(30570786) 教育部新世纪优秀人才支持计划资助项目(NCET-06-0721) 广东省自然科学基金(8151008901000128)
关键词 白血病 细胞凋亡 HL-60细胞 环格列酮 Leukemia Apoptosis HL-60 cells Ciglitazone
  • 相关文献

参考文献13

  • 1Zoete V,Grosdidier A,Michielin O.Peroxisome proliferatoractivated receptor structures:ligand specificity,molecular switch and interactions with regulators.Biochim Biophys Acta,2007,1771:915-925.
  • 2Ulivieri C,Baldari CT.The potential of peroxisome proliferator-activated receptor gamma (PPAR gamma) ligands in the treatment of hematological malignancies.Mini Rev Med Chem,2007,7:877-887.
  • 3Wang T,Xu J,Yu X,et al.Peroxisome proliferator-aetivated receptorγ in malignant diseases.Crit Rev Oncol Hematol,2006,58:1-14.
  • 4Liu J,Lu H,Huang R,et al.Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinaae activity in human myeloid leukemia cells.Cancer Chemother Pharmacol,2005,56:400-408.
  • 5Liu JJ,Liu PQ,Lin DJ,et al.Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.Ann Hematol,2007,86:173-183.
  • 6Cuevas BD,Abell AN,Johnson GL.Role of mitogen-activated protein kinase kinase kinases in signal integration.Oncogene,2007,14:3159-3171.
  • 7Kim EK,Choi EJ.Pathological roles of MAPK signaling pathways in human diseases.Biochim Biophys Acta,2010,1802:396-405.
  • 8Wagner EF,Nebreda AR.Signal integration by JNK and p38MAPK pathways in cancer development.Nat Rev Cancer,2009,9:537-549.
  • 9Buchanan C,Stigliano I,Garay-Malpartida HM,et al.Glypican-3reexpression regulates apoptosis in murine adenocarcinoma mannary cells modulating PI3K/Akt and p38MAPK signaling pathways.Breast Cancer Res Treat,2010,119:559-574.
  • 10Doepfner KT,Boller D,Arcaro A.Targeting receptor tyrosine kinase signaling in acute myeloid leukemia Crit Rev Oncol Hematol,2007,63:215-230.

同被引文献17

  • 1樊华,杜宏,张国君,王萍萍,王艳萍,卢香兰,李霞,金锋.VEGF和N-Ras及pERK1/2在急性髓系白血病骨髓中的表达及相关性研究[J].肿瘤防治杂志,2005,12(12):903-906. 被引量:4
  • 2许民,乔振华,鹿育晋,朱镭,许莲蓉.FTI-277对髓系白血病细胞的抗增生作用与抑制ERK/MAPK信号途径的关系[J].白血病.淋巴瘤,2006,15(3):170-173. 被引量:1
  • 3Hang-Lung Chang,Chih-Yu Chen,Ya-Fen Hsu,Wen-Shin Kuo,George Ou,Pei-Ting Chiu,Yu-Han Huang,Ming-Jen Hsu.Simvastatin induced HCT116 colorectal cancer cell apoptosis through p38MAPK-p53- survivin signaling cascade[J].BBA - General Subjects.2013
  • 4Xiu Dong,Jian-Chun Li,Yuan-Yuan Jiang,Ming-Yu Xia,Shin-Ichi Tashiro,Satoshi Onodera,Takashi Ikejima.p38–NF-κB-promoted mitochondria-associated apoptosis and G2/M cell cycle arrest in norcantharidin-treated HeLa cells[J].Journal of Asian Natural Products Research.2012(11)
  • 5Peng Wang,Jinpu Yu,Qiang Yin,Wenliang Li,Xiubao Ren,Xishan Hao.Rosiglitazone Suppresses Glioma Cell Growth and Cell Cycle by Blocking the Transforming Growth Factor-Beta Mediated Pathway[J].Neurochemical Research.2012(10)
  • 6Jia-Jun Liu,Xue-Jun Dai,Yan Xu,Pei-Qing Liu,Yong Zhang,Xiao-Dan Liu,Zhi-Gang Fang,Dong-Jun Lin,Ruo-Zhi Xiao,Ren-Wei Huang,He-Qing Huang.Inhibition of Lymphoma Cell Proliferation by Peroxisomal Proliferator-Activated Receptor-γ Ligands via Wnt Signaling Pathway[J].Cell Biochemistry and Biophysics.2012(1)
  • 7Ajaya Kumar Reka,Moloy T. Goswami,Rashmi Krishnapuram,Theodore J. Standiford,Venkateshwar G. Keshamouni.Molecular cross-regulation between PPAR-γ and other signaling pathways: Implications for lung cancer therapy[J].Lung Cancer.2011(2)
  • 8Megumi Fujita,Tatsurou Yagami,Miki Fujio,Chiaki Tohji,Kenkichi Takase,Yasuhiro Yamamoto,Kyoko Sawada,Motohiro Yamamori,Noboru Okamura.Cytotoxicity of troglitazone through PPARγ-independent pathway and p38 MAPK pathway in renal cell carcinoma[J].Cancer Letters.2011(2)
  • 9Wei-Ting Lee,Chia-Wen Chang.Bax is upregulated by p53 signal pathway in the SPE B-induced apoptosis[J].Molecular and Cellular Biochemistry (-).2010(1-2)
  • 10郭晓,董春杰,宋丹,李文静,潘岐.p38丝裂原活化蛋白激酶阻滞剂SB203580对白血病K562细胞周期的作用及机制[J].白血病.淋巴瘤,2009,18(8):449-451. 被引量:1

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部